PPM America Capital Partners Elevates Tiffany Luna to Partner

PPM America Capital Partners, a Chicago-based middle-market private equity firm, has promoted Tiffany Luna to Partner, the firm announced March 12. The elevation recognizes Luna's contributions to portfolio company operations and value creation across the firm's healthcare and business services investments over the past decade.

Luna joined PPM in 2016 as a Principal focused on operational improvement and strategic initiatives across the firm's portfolio. Her promotion to Partner comes as middle-market private equity firms increasingly prioritize operational expertise alongside traditional deal-making capabilities, reflecting an industry-wide shift toward hands-on value creation in an environment of elevated purchase price multiples and compressed arbitrage opportunities.

"Tiffany has been instrumental in driving operational excellence and strategic growth initiatives across our portfolio," said David Stahl, Managing Partner at PPM America Capital Partners. "Her deep expertise in healthcare operations and business services, combined with her ability to partner with management teams to unlock value, has been transformative for our companies and their stakeholders."

The promotion comes amid a broader trend in private equity where operational partners are gaining prominence within firm leadership structures. According to Bain & Company's Global Private Equity Report, operational value creation now accounts for approximately 40% of value generated in private equity deals, up from 25% a decade ago, as multiple arbitrage opportunities have diminished in highly competitive deal markets.

Luna brings more than 15 years of operational and strategic experience to her expanded role, with particular depth in healthcare services, medical technology, and specialized business services. Prior to joining PPM, she held senior operating roles at several healthcare companies, including a five-year tenure as Chief Operating Officer at a regional physician practice management organization where she oversaw 40+ locations across the Midwest.

Her earlier career included positions at McKinsey & Company and operational leadership roles in the healthcare technology sector, providing her with a unique blend of strategic consulting frameworks and hands-on execution experience. Luna holds an MBA from the University of Chicago Booth School of Business and a Bachelor's degree in Industrial Engineering from Northwestern University.

During her tenure at PPM, Luna has worked across more than a dozen portfolio companies, leading initiatives ranging from revenue optimization and operational efficiency to strategic acquisitions and digital transformation. Her work has been particularly impactful in healthcare services investments, where regulatory complexity and operational intricacies require specialized domain expertise.

"The healthcare services landscape has become increasingly complex, with evolving reimbursement models, regulatory changes, and accelerating consolidation," Luna said in the announcement. "Our ability to partner with management teams to navigate these dynamics while driving sustainable growth has been central to our investment approach and portfolio company success."

PPM America Capital Partners, founded in 1998, focuses on control equity investments in middle-market healthcare, business services, and specialty manufacturing companies with enterprise values typically ranging from $100 million to $500 million. The firm currently manages approximately $2.8 billion in committed capital across three active funds and maintains a concentrated portfolio approach, typically holding 8-12 platform investments at any given time.

The firm's healthcare portfolio has included investments across physician practice management, specialty pharmacy, behavioral health services, and medical technology distribution. Recent investments have focused on fragmented healthcare services sectors experiencing consolidation tailwinds, regulatory changes creating operational complexity, and demographic trends driving secular growth.

In the business services sector, PPM targets specialized B2B services with recurring revenue models, high switching costs, and opportunities for geographic expansion or add-on acquisitions. The firm's buy-and-build strategy has been particularly active in recent years, with portfolio companies completing more than 40 add-on acquisitions since 2020 according to PitchBook data.

Luna's promotion reflects PPM's strategic emphasis on operational value creation, particularly in healthcare investments where regulatory navigation, payor relationships, and clinical quality metrics require specialized expertise beyond traditional financial engineering.

The elevation of an operational partner to the firm's senior leadership ranks aligns with broader private equity industry trends. As entry multiples for middle-market healthcare and business services companies have reached 10-12x EBITDA according to recent Lincoln International data, firms have increasingly turned to operational improvements and strategic initiatives to drive returns rather than relying primarily on multiple arbitrage or financial leverage.

Luna's expertise comes at a pivotal moment for healthcare services private equity. The sector has seen explosive growth in private equity activity over the past five years, with healthcare services deal volume increasing 45% between 2020 and 2025 according to PitchBook, driven by aging demographics, shift to value-based care models, and continued fragmentation in specialty physician practices and ancillary services.

Regulatory tailwinds have also accelerated consolidation. The transition from fee-for-service to value-based reimbursement models has created operational complexity that favors scaled platforms with sophisticated data analytics, care coordination capabilities, and payor contracting expertise. Independent physician practices and smaller healthcare service providers increasingly seek private equity partnerships to navigate these changes while maintaining clinical autonomy.

"The healthcare services landscape is undergoing fundamental transformation," noted Dr. James Robinson, health economist at UC Berkeley. "Private equity firms with deep operational expertise and sector knowledge are increasingly valued partners for healthcare providers navigating value-based care, regulatory compliance, and technology adoption."

However, the sector has also faced scrutiny from regulators and policymakers concerned about the impact of private equity ownership on healthcare access, quality, and costs. The Federal Trade Commission has increased scrutiny of healthcare services roll-ups, particularly in markets where consolidation could reduce competition or increase prices. This regulatory environment places a premium on operational partners who can demonstrate value creation through quality improvement, operational efficiency, and patient outcomes rather than pricing power alone.

PPM has positioned itself as a long-term partner focused on sustainable growth and operational improvement. The firm's investment approach emphasizes clinical quality metrics, patient satisfaction scores, and employee engagement alongside traditional financial metrics—an approach that resonates with healthcare management teams and helps differentiate the firm in competitive deal processes.

Beyond healthcare, Luna has been instrumental in PPM's business services investments, a sector that has seen robust deal activity as companies seek specialized expertise in areas ranging from compliance and regulatory services to technology-enabled workflow solutions. The business services sector accounted for approximately 30% of middle-market private equity deal volume in 2025, reflecting strong investor appetite for recurring revenue models and fragmented markets conducive to buy-and-build strategies.

PPM's business services portfolio has focused on subsectors with high barriers to entry, regulatory complexity, or specialized expertise that create customer stickiness and pricing power. Recent investments have included regulatory compliance services, specialized staffing, and technology-enabled business process outsourcing—all areas where Luna's operational background has proven valuable in driving organic growth and integration excellence.

Luna's promotion reflects a fundamental shift in private equity firm structures. Historically dominated by investment professionals with backgrounds in investment banking, consulting, or prior private equity experience, leading firms now increasingly recruit operational executives with deep domain expertise and hands-on management experience.

This evolution has been driven by multiple factors. First, elevated purchase price multiples have compressed returns from financial engineering and multiple arbitrage, forcing firms to focus on operational improvements and organic growth. Second, increasing complexity in sectors like healthcare, technology, and industrial services requires specialized knowledge that traditional generalist investors may lack. Third, management teams increasingly seek private equity partners who can provide strategic and operational support beyond capital.

"The era of private equity as purely financial investors is over," said Steven Kaplan, professor of finance at University of Chicago Booth School of Business. "Today's leading firms combine financial acumen with operational expertise, sector knowledge, and strategic capabilities. The most successful partnerships are those where the private equity firm genuinely adds value beyond the balance sheet."

Many middle-market firms have established formal operating partner programs, recruiting former CEOs, COOs, and functional executives to work alongside investment teams. These operational partners typically focus on value creation planning, performance improvement, organizational development, and strategic initiatives rather than deal sourcing and execution, though increasingly they participate in both dimensions.

Luna's promotion also highlights ongoing efforts to improve gender diversity in private equity leadership, though progress remains gradual. Women represented approximately 20% of private equity senior investment professionals in 2025 according to Preqin data, up from 15% in 2020 but still well below gender parity. At the partner and managing director levels, women's representation drops to approximately 12%, underscoring the pipeline challenges facing the industry.

Several factors contribute to this disparity, including historical recruiting patterns that favored male-dominated investment banking and consulting feeder pools, firm cultures that didn't always accommodate work-life integration, and network effects that perpetuated homogeneous teams. However, growing recognition of the business case for diversity—including research showing diverse teams make better investment decisions—has spurred increased focus on recruiting and retaining women in private equity.

Luna's work at PPM has spanned the full spectrum of operational value creation, from commercial excellence and operational efficiency to digital transformation and strategic M&A. In healthcare portfolio companies, she has led initiatives to optimize revenue cycle management, improve clinical outcomes measurement, enhance patient engagement, and develop value-based care capabilities—all critical priorities as the industry shifts from volume to value.

One notable engagement involved a specialty physician practice management platform where Luna led a comprehensive revenue cycle optimization initiative that reduced days sales outstanding by 28%, improved collections rates by 12 percentage points, and enhanced payor contract terms through data-driven negotiations. The initiatives generated more than $15 million in annual EBITDA improvement while improving patient satisfaction scores.

In business services investments, Luna has focused on sales force effectiveness, pricing optimization, and service delivery excellence. Her work with a specialized staffing platform included implementing a proprietary technology platform for candidate matching, developing predictive analytics for client retention, and establishing standardized service delivery processes that improved gross margins while enhancing client satisfaction.

Luna has also played a key role in PPM's buy-and-build strategies, working with portfolio company management teams to develop acquisition criteria, screen potential targets, lead operational due diligence, and execute post-merger integration. Her involvement has been particularly valuable in complex healthcare integrations where clinical workflows, regulatory compliance, and provider cultures require careful navigation.

While private equity firms typically don't disclose detailed performance metrics, PPM has generated strong returns across its fund series according to limited partner reports and industry databases. The firm's Fund III, a $850 million vehicle raised in 2019, has generated a gross multiple of invested capital (MOIC) of approximately 2.1x and an internal rate of return in the mid-20% range as of December 2025, placing it in the top quartile of middle-market buyout funds of that vintage.

PPM's investment approach emphasizes downside protection through careful underwriting, operational due diligence, and conservative capital structures, while pursuing upside through operational improvements, strategic acquisitions, and market positioning. The firm typically targets companies with EBITDA between $15 million and $75 million, using equity checks of $50 million to $200 million and moderate leverage of 3-4x EBITDA.

The firm raised its fourth flagship fund in 2024, securing $1.2 billion in commitments from institutional investors including public pension funds, endowments, insurance companies, and family offices. The oversubscribed fundraise, which exceeded the firm's initial $1 billion target, reflects strong investor demand for middle-market strategies with demonstrated operational value creation capabilities.

Fund IV's investment strategy continues PPM's focus on healthcare services, business services, and specialty manufacturing, with particular emphasis on sectors experiencing secular growth tailwinds, fragmentation, and regulatory complexity. The fund has deployed approximately $300 million across four platform investments since closing in mid-2024, maintaining the firm's disciplined approach to deal selection and valuation.

PPM operates in an increasingly competitive middle-market private equity environment, where hundreds of firms compete for quality deals and differentiation has become paramount. The middle market has attracted significant capital in recent years as investors seek exposure to private equity while avoiding the ultra-competitive large-cap market where mega-funds drive valuations to record levels.

Healthcare services has been particularly competitive, with specialist healthcare private equity firms like Webster Equity Partners, Shore Capital Partners, and Chicago Pacific Founders competing alongside generalist middle-market firms for attractive assets. Differentiation increasingly comes from sector expertise, operational capabilities, and track records of successful partnerships with management teams.

"The middle market remains attractive because of structural fragmentation and opportunities for operational improvement," noted Campbell Harvey, professor of finance at Duke University. "But success requires more than capital—it demands sector knowledge, operational expertise, and the ability to execute complex buy-and-build strategies. Firms that can demonstrate these capabilities have significant competitive advantages."

PPM has sought to differentiate itself through its concentrated portfolio approach, deep operational involvement, and long-term partnership orientation. The firm typically holds investments for 5-7 years, longer than the middle-market average of 4-5 years, reflecting its focus on fundamental value creation rather than quick flips. This patient capital approach has resonated with management teams seeking partners committed to building sustainable businesses rather than maximizing short-term exit multiples.

Looking ahead, Luna's expanded role will focus on deepening PPM's operational capabilities across the portfolio, enhancing the firm's healthcare services expertise, and contributing to investment strategy and portfolio construction. She will also play a more prominent role in fundraising, limited partner relations, and firm management as part of the senior leadership team.

"This promotion recognizes Tiffany's exceptional contributions and positions our firm for continued growth," Stahl said. "As we deploy Fund IV and prepare for future fundraising, having operational expertise at the partnership level strengthens our value proposition to both management teams and limited partners. Tiffany's leadership will be instrumental as we execute our strategy in increasingly complex healthcare and business services markets."

For Luna, the promotion represents validation of the operational approach to private equity and the growing recognition that value creation requires hands-on expertise. "I'm honored to join the partnership and excited about our opportunity to continue building great businesses," she said. "The middle market offers tremendous opportunities for firms that can combine capital with strategic thinking and operational execution. That's where we excel, and I look forward to expanding our impact across the portfolio."

The firm expects to remain active in healthcare services and business services deal flow throughout 2026, targeting platform investments in specialty physician practices, post-acute care services, regulatory compliance providers, and specialized staffing businesses. With Fund IV approximately 25% deployed, PPM has significant dry powder for new platforms and add-on acquisitions as market conditions evolve and attractive opportunities emerge.